AGILYSYS INC (AGYS) Fundamental Analysis & Valuation

NASDAQ:AGYS • US00847J1051

69.95 USD
-2.55 (-3.52%)
At close: Mar 12, 2026
69.95 USD
0 (0%)
After Hours: 3/12/2026, 8:22:31 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This AGYS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to AGYS. AGYS was compared to 277 industry peers in the Software industry. While AGYS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. AGYS is valued quite expensively, but it does show have an excellent growth rating. These ratings could make AGYS a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. AGYS Profitability Analysis

1.1 Basic Checks

  • AGYS had positive earnings in the past year.
  • AGYS had a positive operating cash flow in the past year.
  • AGYS had positive earnings in 4 of the past 5 years.
  • In the past 5 years AGYS always reported a positive cash flow from operatings.
AGYS Yearly Net Income VS EBIT VS OCF VS FCFAGYS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M

1.2 Ratios

  • The Return On Assets of AGYS (6.40%) is better than 76.53% of its industry peers.
  • AGYS's Return On Equity of 9.72% is fine compared to the rest of the industry. AGYS outperforms 74.01% of its industry peers.
  • AGYS's Return On Invested Capital of 7.91% is fine compared to the rest of the industry. AGYS outperforms 79.78% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for AGYS is below the industry average of 10.89%.
  • The last Return On Invested Capital (7.91%) for AGYS is above the 3 year average (7.16%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.4%
ROE 9.72%
ROIC 7.91%
ROA(3y)11.61%
ROA(5y)4.91%
ROE(3y)17.82%
ROE(5y)7.29%
ROIC(3y)7.16%
ROIC(5y)N/A
AGYS Yearly ROA, ROE, ROICAGYS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

  • Looking at the Profit Margin, with a value of 9.79%, AGYS is in the better half of the industry, outperforming 72.92% of the companies in the same industry.
  • AGYS's Profit Margin has improved in the last couple of years.
  • AGYS has a better Operating Margin (9.71%) than 76.53% of its industry peers.
  • AGYS's Operating Margin has improved in the last couple of years.
  • AGYS has a worse Gross Margin (61.67%) than 60.29% of its industry peers.
  • AGYS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.71%
PM (TTM) 9.79%
GM 61.67%
OM growth 3Y22.98%
OM growth 5YN/A
PM growth 3Y43.88%
PM growth 5YN/A
GM growth 3Y-0.01%
GM growth 5Y4.37%
AGYS Yearly Profit, Operating, Gross MarginsAGYS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. AGYS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AGYS is destroying value.
  • AGYS has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, AGYS has more shares outstanding
  • AGYS has a worse debt/assets ratio than last year.
AGYS Yearly Shares OutstandingAGYS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
AGYS Yearly Total Debt VS Total AssetsAGYS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • An Altman-Z score of 8.80 indicates that AGYS is not in any danger for bankruptcy at the moment.
  • AGYS has a Altman-Z score of 8.80. This is amongst the best in the industry. AGYS outperforms 89.89% of its industry peers.
  • There is no outstanding debt for AGYS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.8
ROIC/WACC0.72
WACC10.99%
AGYS Yearly LT Debt VS Equity VS FCFAGYS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • A Current Ratio of 1.31 indicates that AGYS should not have too much problems paying its short term obligations.
  • AGYS's Current ratio of 1.31 is on the low side compared to the rest of the industry. AGYS is outperformed by 60.29% of its industry peers.
  • AGYS has a Quick Ratio of 1.25. This is a normal value and indicates that AGYS is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of AGYS (1.25) is worse than 62.82% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.25
AGYS Yearly Current Assets VS Current LiabilitesAGYS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. AGYS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 26.12% over the past year.
  • The Earnings Per Share has been growing by 47.96% on average over the past years. This is a very strong growth
  • The Revenue has grown by 17.86% in the past year. This is quite good.
  • AGYS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.38% yearly.
EPS 1Y (TTM)26.12%
EPS 3Y23.91%
EPS 5Y47.96%
EPS Q2Q%10.53%
Revenue 1Y (TTM)17.86%
Revenue growth 3Y19.23%
Revenue growth 5Y11.38%
Sales Q2Q%15.57%

3.2 Future

  • AGYS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.38% yearly.
  • Based on estimates for the next years, AGYS will show a very strong growth in Revenue. The Revenue will grow by 21.76% on average per year.
EPS Next Y7.56%
EPS Next 2Y18.7%
EPS Next 3Y21.38%
EPS Next 5YN/A
Revenue Next Year16.54%
Revenue Next 2Y15.44%
Revenue Next 3Y15.02%
Revenue Next 5Y21.76%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AGYS Yearly Revenue VS EstimatesAGYS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
AGYS Yearly EPS VS EstimatesAGYS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

3

4. AGYS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 41.39, AGYS can be considered very expensive at the moment.
  • AGYS's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 25.71. AGYS is valued rather expensively when compared to this.
  • Based on the Price/Forward Earnings ratio of 31.82, the valuation of AGYS can be described as expensive.
  • The rest of the industry has a similar Price/Forward Earnings ratio as AGYS.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.82, AGYS is valued a bit more expensive.
Industry RankSector Rank
PE 41.39
Fwd PE 31.82
AGYS Price Earnings VS Forward Price EarningsAGYS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • AGYS's Enterprise Value to EBITDA is on the same level as the industry average.
  • 61.37% of the companies in the same industry are more expensive than AGYS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 33.22
EV/EBITDA 46.7
AGYS Per share dataAGYS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AGYS does not grow enough to justify the current Price/Earnings ratio.
  • AGYS has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as AGYS's earnings are expected to grow with 21.38% in the coming years.
PEG (NY)5.48
PEG (5Y)0.86
EPS Next 2Y18.7%
EPS Next 3Y21.38%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AGYS Dividend Analysis

5.1 Amount

  • No dividends for AGYS!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AGYS Fundamentals: All Metrics, Ratios and Statistics

AGILYSYS INC

NASDAQ:AGYS (3/12/2026, 8:22:31 PM)

After market: 69.95 0 (0%)

69.95

-2.55 (-3.52%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)01-26
Earnings (Next)05-18
Inst Owners108.27%
Inst Owner Change-0.61%
Ins Owners4.27%
Ins Owner Change1.56%
Market Cap1.97B
Revenue(TTM)310.64M
Net Income(TTM)30.42M
Analysts81.43
Price Target139.11 (98.87%)
Short Float %6.34%
Short Ratio5.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.76%
Min EPS beat(2)-9.64%
Max EPS beat(2)2.12%
EPS beat(4)2
Avg EPS beat(4)16.71%
Min EPS beat(4)-10.75%
Max EPS beat(4)85.11%
EPS beat(8)6
Avg EPS beat(8)14.3%
EPS beat(12)10
Avg EPS beat(12)18.27%
EPS beat(16)14
Avg EPS beat(16)20.42%
Revenue beat(2)1
Avg Revenue beat(2)0.44%
Min Revenue beat(2)-0.27%
Max Revenue beat(2)1.14%
Revenue beat(4)3
Avg Revenue beat(4)0.98%
Min Revenue beat(4)-0.27%
Max Revenue beat(4)1.95%
Revenue beat(8)3
Avg Revenue beat(8)-1.08%
Revenue beat(12)4
Avg Revenue beat(12)-0.78%
Revenue beat(16)8
Avg Revenue beat(16)0.02%
PT rev (1m)-2.39%
PT rev (3m)-2.39%
EPS NQ rev (1m)2.88%
EPS NQ rev (3m)4.69%
EPS NY rev (1m)1.17%
EPS NY rev (3m)-1%
Revenue NQ rev (1m)0.1%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)0.77%
Valuation
Industry RankSector Rank
PE 41.39
Fwd PE 31.82
P/S 6.33
P/FCF 33.22
P/OCF 32.07
P/B 6.28
P/tB 18.12
EV/EBITDA 46.7
EPS(TTM)1.69
EY2.42%
EPS(NY)2.2
Fwd EY3.14%
FCF(TTM)2.11
FCFY3.01%
OCF(TTM)2.18
OCFY3.12%
SpS11.05
BVpS11.14
TBVpS3.86
PEG (NY)5.48
PEG (5Y)0.86
Graham Number20.58
Profitability
Industry RankSector Rank
ROA 6.4%
ROE 9.72%
ROCE 8.73%
ROIC 7.91%
ROICexc 10.35%
ROICexgc 46.15%
OM 9.71%
PM (TTM) 9.79%
GM 61.67%
FCFM 19.05%
ROA(3y)11.61%
ROA(5y)4.91%
ROE(3y)17.82%
ROE(5y)7.29%
ROIC(3y)7.16%
ROIC(5y)N/A
ROICexc(3y)15.95%
ROICexc(5y)N/A
ROICexgc(3y)439.05%
ROICexgc(5y)N/A
ROCE(3y)7.91%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-16.81%
ROICexc growth 5YN/A
OM growth 3Y22.98%
OM growth 5YN/A
PM growth 3Y43.88%
PM growth 5YN/A
GM growth 3Y-0.01%
GM growth 5Y4.37%
F-Score7
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 20.82%
Cap/Sales 0.68%
Interest Coverage 250
Cash Conversion 151.93%
Profit Quality 194.56%
Current Ratio 1.31
Quick Ratio 1.25
Altman-Z 8.8
F-Score7
WACC10.99%
ROIC/WACC0.72
Cap/Depr(3y)131.65%
Cap/Depr(5y)90.98%
Cap/Sales(3y)2.69%
Cap/Sales(5y)1.97%
Profit Quality(3y)162.49%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.12%
EPS 3Y23.91%
EPS 5Y47.96%
EPS Q2Q%10.53%
EPS Next Y7.56%
EPS Next 2Y18.7%
EPS Next 3Y21.38%
EPS Next 5YN/A
Revenue 1Y (TTM)17.86%
Revenue growth 3Y19.23%
Revenue growth 5Y11.38%
Sales Q2Q%15.57%
Revenue Next Year16.54%
Revenue Next 2Y15.44%
Revenue Next 3Y15.02%
Revenue Next 5Y21.76%
EBIT growth 1Y16.97%
EBIT growth 3Y46.64%
EBIT growth 5YN/A
EBIT Next Year197.99%
EBIT Next 3Y68.08%
EBIT Next 5Y56.79%
FCF growth 1Y147.44%
FCF growth 3Y24.23%
FCF growth 5Y48.7%
OCF growth 1Y74.29%
OCF growth 3Y24.6%
OCF growth 5Y39.06%

AGILYSYS INC / AGYS FAQ

Can you provide the ChartMill fundamental rating for AGILYSYS INC?

ChartMill assigns a fundamental rating of 6 / 10 to AGYS.


What is the valuation status for AGYS stock?

ChartMill assigns a valuation rating of 3 / 10 to AGILYSYS INC (AGYS). This can be considered as Overvalued.


Can you provide the profitability details for AGILYSYS INC?

AGILYSYS INC (AGYS) has a profitability rating of 7 / 10.


How financially healthy is AGILYSYS INC?

The financial health rating of AGILYSYS INC (AGYS) is 6 / 10.


Can you provide the expected EPS growth for AGYS stock?

The Earnings per Share (EPS) of AGILYSYS INC (AGYS) is expected to grow by 7.56% in the next year.